sitagliptin bioton 25 mg tabletki powlekane
bioton s.a. - sitagliptin hydrochloride monohydrate - tabletki powlekane - 25 mg
sitagliptin bioton 50 mg tabletki powlekane
bioton s.a. - sitagliptin hydrochloride monohydrate - tabletki powlekane - 50 mg
sitagliptin grindeks 50 mg tabletki powlekane
as grindeks - sitagliptin hydrochloride monohydrate - tabletki powlekane - 50 mg
sitagliptin grindeks 25 mg tabletki powlekane
as grindeks - sitagliptin hydrochloride monohydrate - tabletki powlekane - 25 mg
sitagliptin grindeks 100 mg tabletki powlekane
as grindeks - sitagliptin hydrochloride monohydrate - tabletki powlekane - 100 mg
sitagliptin sandoz 100 mg tabletki powlekane
sandoz gmbh - sitagliptin hydrochloride monohydrate - tabletki powlekane - 100 mg
sitagliptin sandoz 25 mg tabletki powlekane
sandoz gmbh - sitagliptin hydrochloride monohydrate - tabletki powlekane - 25 mg
sitagliptin sandoz 50 mg tabletki powlekane
sandoz gmbh - sitagliptin hydrochloride monohydrate - tabletki powlekane - 50 mg
sitagliptin / metformin hydrochloride accord
accord healthcare s.l.u. - metformin hydrochloride, sitagliptin hydrochloride monohydrate - diabetes mellitus, type 2 - leki stosowane w cukrzycy - for adult patients with type 2 diabetes mellitus:it is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. it is indicated in combination with a sulphonylurea (i. potrójnej terapii skojarzonej), jako uzupełnienie diety i ćwiczeń fizycznych u pacjentów niedostatecznie kontrolowanych o ich maksymalnej tolerowanej dawki sulfonylomocznika z metforminą i. it is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. it is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.
sitagliptin aflofarm 100 mg tabletki powlekane
aflofarm farmacja polska sp. z o.o. - sitagliptini hydrochloridum monohydricum - tabletki powlekane - 100 mg